Johnson Marvin 4
4 · MARINUS PHARMACEUTICALS, INC. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Johnson Marvin
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-18+20,900→ 20,900 totalExercise: $9.74Exp: 2034-01-18→ Common Stock (20,900 underlying) - Award
Common Stock
2024-01-18+4,600→ 11,800 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 18, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
- [F2]The option vests and becomes exercisable in 12 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer.